| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.843 | 3.340 | 335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 9.843 | 3.340 | 335 | 9.012 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 488 | 854 | 751 | 164 | 58 | 120 | 119 | 118 | 0 | 0 |
| Gross Profit/Loss - EUR | 9.355 | 2.486 | -415 | 8.848 | -58 | -120 | -119 | -118 | 0 | 0 |
| Net Profit/Loss - EUR | 9.060 | 2.386 | -426 | 8.578 | -58 | -120 | -119 | -118 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oftarom S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 307 | 906 | 162 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 14.165 | 15.603 | 15.652 | 24.372 | 11.143 | 10.812 | 10.452 | 6.428 | 6.409 | 6.373 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 6.008 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 14.165 | 15.603 | 15.652 | 18.363 | 11.143 | 10.812 | 10.452 | 6.428 | 6.409 | 6.373 |
| Shareholders Funds | -3.365 | -945 | -1.354 | 7.248 | 7.049 | 6.796 | 6.525 | 6.428 | 6.409 | 6.373 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.838 | 17.453 | 17.168 | 17.123 | 4.094 | 4.016 | 3.927 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftarom S.r.l.